5.4 | | KRT38 | 'triple-negative breast cancer; breast carcinoma' vs 'normal' | clinical information, disease | RNA-seq of 17 breast tumor samples of three different subtypes and normal human breast organoids samples |
-4.9 | | KRT38 | 'erythroleukemia; ZRSR2 shRNA' vs 'normal' | disease, genotype | RNA-seq of bone marrow from patients with myelodysplastic syndrome |
4.1 | | KRT38 | 'hypoxia' vs 'normoxia' in 'SNF96.2' | cell line, growth condition | Hypoxia and Intrinsic Transcriptomic Subtyping of Soft Tissue Sarcoma |
3.8 | | KRT38 | 'non-triple-negative breast cancer; breast carcinoma' vs 'normal' | clinical information, disease | RNA-seq of 17 breast tumor samples of three different subtypes and normal human breast organoids samples |
-3.1 | | KRT38 | 'Barrett’s esophagus; non-dysplastic' vs 'normal' | disease, disease staging | Whole transcriptome profiling of Esophageal adenocarcinoma and Barrett's |
2.8 | | KRT38 | 'SFRP2 overexpression' vs 'wild type' in 'U-2987' | cell line, phenotype | RNA-seq of human glioblastoma cell lines with overexpression of SOX2, SFRP2 |
-2.7 | | KRT38 | 'sebaceous of Jadassohn nevus' vs 'normal' | block, disease | RNA-seq of a panel of non-melanoma skin cancer lesions |
-2.4 | | KRT38 | 'familial hemophagocytic lymphohistiocytosis 5' vs 'normal' | disease | RNAseq on PBMC of three patients with Familial Hemophagocytic Lymphohistiocytosis Type 5 (FHL5) and three age and sex-matched controls |
2.1 | | KRT38 | 'differentiated; hAKPC-P' vs 'undifferentiated; hIPod' | cell type, phenotype | Differentiation of human amniotic fluid kidney progenitor cells into podocytes and comparison with human conditionally immortalized podocytes |
-2 | | KRT38 | 'giantin knockout' vs 'wild type' | phenotype | RNAseq of wild-type and giantin knockout retinal pigment epithelial cell lines |
2 | | KRT38 | 'late passage' vs 'early passage' | phenotype | Transcription profiling by high throughput sequencing in late (P13) and early P(4) passage cells |
-2 | | KRT38 | 'breast carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
1.9 | | KRT38 | 'differentiated; hAKPC-P' vs 're-differentiated; hIPod' | cell type, phenotype | Differentiation of human amniotic fluid kidney progenitor cells into podocytes and comparison with human conditionally immortalized podocytes |
1.7 | | KRT38 | 'differentiated; hAKPC-P' vs 'undifferentiated; hAKPC-P' | cell type, phenotype | Differentiation of human amniotic fluid kidney progenitor cells into podocytes and comparison with human conditionally immortalized podocytes |
1.5 | | KRT38 | 'OVOL1 overexpression; mesenchymal' vs 'control; epithelial transformed to Mesenchymal' | cell type, genotype | Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer |
1.4 | | KRT38 | 'blood alcohol content 0.04%rising' vs 'control' in 'time point 2' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
1.4 | | KRT38 | 'blood alcohol content 0%' vs 'control' in 'time point 1' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
-1.4 | | KRT38 | 'kidney transplant; tolerance' vs 'none; none' | clinical history, clinical information | Intragraft molecular pathways associated with tolerance induction in renal transplantation |
1.3 | | KRT38 | 'blood alcohol content 0.04%declining' vs 'control' in 'time point 4' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
1.2 | | KRT38 | 'blood alcohol content 0.02%declining' vs 'control' in 'time point 5' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
-1.2 | | KRT38 | 'kidney transplant; rejection' vs 'none; none' | clinical history, clinical information | Intragraft molecular pathways associated with tolerance induction in renal transplantation |
1.2 | | KRT38 | 'cultured skin substitute; 28 day' vs 'skin; 0 day' | organism part, time | Transcription profiling by array of human grafted engineered skin substitutes |
1.1 | | KRT38 | 'ovarian cancer' vs 'normal' in 'epithelial cell' | cell type, disease | A cancer associated fibroblasts (CAFs) specific gene signature in high grade serous ovarian cancer |
1.1 | | KRT38 | 'blood alcohol content 0.08%' vs 'control' in 'time point 3' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
1.1 | | KRT38 | 'medulloblastoma, large-cell' vs 'normal' | disease | Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes |
1.1 | | KRT38 | 'hypoxia' vs 'normoxia' in 'MDAMB468; DMEM-F12 media' | cell line, environmental stress, growth condition | RNA-seq of human breast cancer cell lines: CAL120; MDAMB468 and BT549 incubated in DMEM-F12 and Plasmax in normoxia (21%O2) and hypoxia (0.1% O2) |
1 | | KRT38 | 'osteosarcoma' vs 'normal' | disease | Transcription profiling by array of human bone specimens from patients with osteosarcoma |
1 | | KRT38 | 'erythematotelangiectatic rosacea' vs 'healthy' | clinical information | Transcription profiling of three cutaneous rosacea subtypes to characterize the inflammatory infiltrate |
1 | | KRT38 | 'COX-1 knockdown' vs 'wild type' | phenotype | Transcription profiling by high throughput sequencing of COX-1 knockdown in OVCAR-3 cells |
1 | | KRT38 | 'adult high grade glioma' vs 'normal' | disease | Gene expression profile of pediatric and adult brain tumor types and normal brain |
